Author:
Chen Yuan,Samineni Divya,Mukadam Sophie,Wong Harvey,Shen Ben-Quan,Lu Dan,Girish Sandhya,Hop Cornelis,Jin Jin Yan,Li Chunze
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference18 articles.
1. Sasoon I, Blanc V. Antibody-drug conjugate (ADC) clinical pipeline: a review. Methods Mol Biol. 2013;1045:1–27.
2. Trail PA. Antibody drug conjugates as cancer therapeutics. Antibodies. 2013;2:113–29.
3. Gorovits BA, Alley SC, Bilic S, Booth B, Kaur S, Oldfield P, Purushothama S, Rao C, Shord S, Siguenza P. Bioanalysis of antibody–drug conjugates: American Association of Pharmaceutical Scientists Antibody–Drug Conjugate Working Group position paper. Bioanalysis. 2013;5:997–1006.
4. Kaur S, Xu K, Saad OM, Dere RC, Carrasco-Triguera M. Bioanalytical assay strategies for the development of antibody–drug conjugate biotherapeutics. Bioanalysis. 2013;5:201–26.
5. US FDA, Center for Drug Evaluation and Research. Clinical Pharmacology and Biopharmaceutics Review(s). Application no. 125388 Orig1s000; BLA 125388 and 125399 brentuximab vedotin.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献